MC
BMY icon

Montag & Caldwell’s Bristol-Myers Squibb BMY Stock Holding History

Montag & Caldwell’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$13.9K Hold
300
– – ﹤0.01% 109
2025
Q1 		$18.3K Hold
300
– – ﹤0.01% 107
2024
Q4 		$17K Buy
+300
New +$16.8K ﹤0.01% 113
2017
Q1 		– Sell
-1,074,642
Closed -$62.8M – 88
2016
Q4 		$62.8M Sell
1,074,642
-1,390,927
-56% -$76M 1.52% 28
2016
Q3 		$133M Buy
2,465,569
+1,337,101
+118% +$85.9M 2.79% 17
2016
Q2 		$83M Buy
+1,128,468
New +$79.7M 1.69% 29

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Montag & Caldwell's BMY Position: Q2 2025 in Review

Montag & Caldwell held its Bristol-Myers Squibb (BMY) position steady in Q2 2025 at 300 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #109.

Montag & Caldwell first reported a position in BMY in Q2 2016 and has held it in 6 quarters since. The position peaked at $133M in Q3 2016. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Montag & Caldwell held 300 shares of Bristol-Myers Squibb worth $13.9K as of Q2 2025.
  • Montag & Caldwell left its Bristol-Myers Squibb share count unchanged in Q2 2025.
  • Bristol-Myers Squibb made up ﹤0.01% of Montag & Caldwell's portfolio in Q2 2025, its #109 holding.
  • Montag & Caldwell first reported a position in Bristol-Myers Squibb in Q2 2016 and has held it in 6 quarters since.
  • Montag & Caldwell's Bristol-Myers Squibb position peaked at $133M in Q3 2016.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Montag & Caldwell's 13F filing for Q2 2025, filed 15 Aug 2025.